Eugia Pharma Speclts Drug Patent Portfolio
Eugia Pharma Speclts owns 1 orange book drug protected by 1 US patent Given below is the list of Eugia Pharma Speclts's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9662342 | Formulations of cyclophosphamide liquid concentrate | 26 Jun, 2035 | Active |
Latest Legal Activities on Eugia Pharma Speclts's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Eugia Pharma Speclts.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Year, Large Entity | 30 May, 2024 | US10849916 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 08 May, 2024 | US10993952 (Litigated) |
|
Recordation of Patent Grant Mailed
Critical
| 12 Jul, 2022 | US11382923 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 12 Jul, 2022 | US11382923 |
|
Email Notification
Critical
| 23 Jun, 2022 | US11382923 |
|
Issue Notification Mailed
Critical
| 22 Jun, 2022 | US11382923 |
| Dispatch to FDC | 08 Jun, 2022 | US11382923 |
|
Application Is Considered Ready for Issue
Critical
| 08 Jun, 2022 | US11382923 |
|
Issue Fee Payment Received
Critical
| 06 Jun, 2022 | US11382923 |
|
Issue Fee Payment Verified
Critical
| 06 Jun, 2022 | US11382923 |
| Letter Accepting Correction of Inventorship Under Rule 1.48 | 06 May, 2022 | US11382923 |
|
Email Notification
Critical
| 06 May, 2022 | US11382923 |
| Filing Receipt - Updated | 06 May, 2022 | US11382923 |
| Miscellaneous Incoming Letter | 03 May, 2022 | US11382923 |
|
Email Notification
Critical
| 25 Apr, 2022 | US11382923 |
Eugia Pharma Speclts's Family Patents
Eugia Pharma Speclts drugs have patent protection in a total of 9 countries. It's US patent count contributes only to 38.5% of its total global patent coverage. 2 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click
below to unlock the full patent family tree.
Eugia Pharma Speclts Drug List
Given below is the complete list of Eugia Pharma Speclts's drugs and the patents protecting them.
1. Cyclophosphamide
Cyclophosphamide is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9662342 | Formulations of cyclophosphamide liquid concentrate |
26 Jun, 2035
(10 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Cyclophosphamide's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List